DBT organizes XITH Annual MedTech Summit of Biodesign Program

2017-12-04 09:54:51

Department of Biotechnology (DBT) , Ministry of Science and Technology, has implemented the Biodesign program with the aim to develop innovative and affordable medical devicesBy Team ABLEThe Department of Biotechnology, Ministry of Science and Technology, has implemented the Biodesign program with the aim to develop innovative and affordable medical devices as per unmet clinical needs of India and

Read more

On World AIDS Day, NIH and partners launch HIV vaccine efficacy study

2017-12-04 09:53:07

The National Institutes of Health and partners have launched a large clinical trial to assess whether an experimental HIV vaccine regimen is safe and able to prevent HIV infection By Team ABLEIn line with the World AIDS Day on December 1st, the National Institutes of Health (NIH) and partners have launched a large clinical trial to assess whether an experimental HIV vaccine regimen is safe and abl

Read more

GE introduces healthcare technology company to revolutionize blood collection

2017-12-04 09:52:06

Drawbridge Health is developing proprietary technology designed to integrate draw, collection and sample stabilization into a single device.By Team ABLEGE has recently introduced Drawbridge Health, a privately-held healthcare technology company focused on enabling personal diagnostic testing — anytime, anywhere. Drawbridge Health is developing proprietary technology designed to integrate draw, c

Read more

European Medicines Agency accepts marketing authorization applications for Mylan-Biocon\'s biosimilars Trastuzumab, Pegfilgrastim

2017-12-04 09:51:09

Trastuzumab is used to treat certain HER2-positive breast and gastric cancers. Pegfilgrastim is used to reduce the duration of neutropenia.By Team ABLEMylan N.V. and Biocon Ltd have announced that the European Medicines Agency (EMA) has accepted for review Mylan\'s Marketing Authorization Applications (MAA) for proposed biosimilar trastuzumab and proposed biosimilar pegfilgrastim. Trastuzumab is u

Read more

BIRAC launches AcE Fund

2017-12-04 09:50:17

According to BIRAC, AcE Fund shall invest in and partner with SEBI-registered AIFsBy Team ABLEThe proposed BIRAC AcE (Accelerating Entrepreneurs) Fund (AcE Fund) will operate as “Fund of Funds” to foster R&D and innovation in Biotechnology domains (including areas such as healthcare, pharma, medical devices, agriculture, sanitation to name a few). According to BIRAC, AcE Fund shall invest

Read more

Cancer Genetics, Indian Cooperative Oncology Network (ICON) collaborate to reduce cancer mortality rates

2017-12-04 09:48:13

CGI and ICON’s complementary strengths will be leveraged to train Indian oncologists, share best practices, and bring state of the art technology to India’s oncologists and their patientsBy Team ABLENasdaq-listed Cancer Genetics Inc, which enables precision medicine for oncology through molecular markers and diagnostics, has announced that it has partnered with the Indian Cooperative Oncology

Read more

Bill & Melinda Gates Foundation invests in Phyton Biotech’s R&D pilot for anti-malarial active pharmaceutical ingredients

2017-12-04 09:47:17

Phyton Biotech has received a $400,000 grant from the Bill & Melinda Gates Foundation to fund the R&D of an alternative method of producing artemisininBy Team ABLEPhyton Biotech has received a $400,000 grant from the Bill & Melinda Gates Foundation to fund the research and development of an alternative method of producing artemisinin, a key active pharmaceutical ingredient (API) used t

Read more

Mitra Biotech partners with Israel’s Gotect Diagnostic

2017-12-04 09:46:08

Mitra Biotech has announced an agreement with Gotect Diagnostic for the exclusive right to represent Mitra in Israel.By Team ABLEMitra Biotech has announced an agreement with Gotect Diagnostic for the exclusive right to represent Mitra in Israel.Mitra\'s CANscript platform recreates a patient\'s own tumor microenvironment in vitro, measures multiple parameters to determine whether a tumor is respo

Read more

India, Italy sign MoU for enhanced cooperation in the health sector

2017-12-04 09:45:00

The MoU recognizes the potential for exchanges in the health sector between the two countriesBy Team ABLEIndia and Italy signed a Memorandum of Understanding (MoU) for enhanced cooperation in the health sector, here today. J P Nadda, Union Minister of Health & Family Welfare and Ms. Beatrice Lorenzin, Health Minister of Italy signed the MoU in the presence of senior officers from the Health Mi

Read more

Jubilant Biosys achieves early milestone on a collaborative discovery program with Sanofi

2017-12-04 09:43:42

The milestone reflects the successful transition of a collaborative program to the next phase in the discovery and development process. By Team ABLEBengaluru-based subsidiary of Jubilant Life Sciences Ltd., Jubilant Biosys Ltd has announced that the company has successfully achieved an early stage milestone related to a collaborative program with Sanofi in Frankfurt, Germany focused on metabolic d

Read more